PortfoliosLab logoPortfoliosLab logo
Bruker Corporation (BRKR)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US1167941087
CUSIP
116794108
IPO Date
Aug 4, 2000

Highlights

Market Cap
$5.51B
Enterprise Value
$7.10B
EPS (TTM)
-$0.06
Total Revenue (TTM)
$3.44B
Gross Profit (TTM)
$1.60B
EBITDA (TTM)
$316.00M
Year Range
$28.53 - $56.22
Target Price
$52.13
ROA (TTM)
-0.14%
ROE (TTM)
-0.35%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Bruker Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Bruker Corporation (BRKR) has returned -23.21% so far this year and -13.00% over the past 12 months. Over the last ten years, BRKR has returned 2.54% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Bruker Corporation

1D
5.28%
1M
-9.81%
YTD
-23.21%
6M
11.46%
1Y
-13.00%
3Y*
-22.61%
5Y*
-10.76%
10Y*
2.54%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Aug 4, 2000, BRKR's average daily return is +0.07%, while the average monthly return is +1.29%. At this rate, your investment would double in approximately 4.5 years.

Historically, 54% of months were positive and 46% were negative. The best month was Aug 2000 with a return of +117.9%, while the worst month was Oct 2008 at -69.3%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.

On a daily basis, BRKR closed higher 50% of trading days. The best single day was Jan 14, 2009 with a return of +35.2%, while the worst single day was Jan 8, 2001 at -31.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-5.99%-9.44%-9.81%-23.21%
2025-0.80%-18.80%-11.51%-4.02%-8.39%12.41%-6.72%-11.58%-4.24%19.85%25.35%-3.38%-19.24%
2024-2.68%21.09%8.55%-16.96%-16.02%-2.52%7.37%-1.85%2.78%-18.03%2.37%1.24%-19.99%
20232.59%-1.64%14.39%0.37%-12.61%6.98%-7.03%-4.47%-5.03%-8.51%14.28%12.89%7.82%
2022-20.63%5.73%-8.63%-10.59%8.76%0.45%9.23%-18.24%-5.25%16.55%9.09%1.39%-18.29%
20216.95%5.34%5.48%6.60%1.40%9.42%8.25%7.42%-11.56%2.82%0.91%3.61%55.35%

Benchmark Metrics

Bruker Corporation has an annualized alpha of 8.19%, beta of 1.22, and R² of 0.18 versus S&P 500 Index. Calculated based on daily prices since August 07, 2000.

  • This stock captured 162.84% of S&P 500 Index gains and 155.54% of its losses — amplifying both gains and losses, but participating more in upside than downside.
  • R² of 0.18 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
8.19%
Beta
1.22
0.18
Upside Capture
162.84%
Downside Capture
155.54%

Return for Risk

Risk / Return Rank

BRKR ranks 29 for risk / return — below 29% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


BRKR Risk / Return Rank: 2929
Overall Rank
BRKR Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
BRKR Sortino Ratio Rank: 2929
Sortino Ratio Rank
BRKR Omega Ratio Rank: 2929
Omega Ratio Rank
BRKR Calmar Ratio Rank: 3030
Calmar Ratio Rank
BRKR Martin Ratio Rank: 2828
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Bruker Corporation (BRKR) and compare them to a chosen benchmark (S&P 500 Index).


BRKRBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.24

0.90

-1.14

Sortino ratio

Return per unit of downside risk

0.02

1.39

-1.36

Omega ratio

Gain probability vs. loss probability

1.00

1.21

-0.21

Calmar ratio

Return relative to maximum drawdown

-0.34

1.40

-1.74

Martin ratio

Return relative to average drawdown

-0.76

6.61

-7.37

Explore BRKR risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Bruker Corporation provided a 0.55% dividend yield over the last twelve months, with an annual payout of $0.20 per share. The company has been increasing its dividends for 9 consecutive years.


0.20%0.30%0.40%0.50%0.60%0.70%0.80%$0.00$0.05$0.10$0.15$0.202016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM2025202420232022202120202019201820172016
Dividend$0.20$0.20$0.20$0.20$0.20$0.16$0.16$0.16$0.16$0.16$0.16

Dividend yield

0.55%0.42%0.34%0.27%0.29%0.19%0.30%0.31%0.54%0.47%0.76%

Monthly Dividends

The table displays the monthly dividend distributions for Bruker Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.05$0.05
2025$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.20
2024$0.00$0.05$0.00$0.00$0.00$0.05$0.00$0.05$0.00$0.00$0.00$0.05$0.20
2023$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.20
2022$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.20
2021$0.00$0.00$0.04$0.00$0.04$0.00$0.00$0.04$0.00$0.00$0.04$0.00$0.16

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Bruker Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bruker Corporation was 94.83%, occurring on Mar 12, 2003. Recovery took 4103 trading sessions.

The current Bruker Corporation drawdown is 61.34%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.83%Sep 1, 2000631Mar 12, 20034103Jun 28, 20194734
-68.72%Mar 22, 2024363Sep 3, 2025
-46.31%Sep 7, 2021266Sep 26, 2022363Mar 7, 2024629
-41.49%Jan 17, 202052Apr 1, 2020173Dec 7, 2020225
-22.01%Jul 8, 201928Aug 14, 201974Nov 27, 2019102

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bruker Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Bruker Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for BRKR relative to other companies in the Medical Devices industry. Currently, BRKR has a P/S ratio of 1.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for BRKR in comparison with other companies in the Medical Devices industry. Currently, BRKR has a P/B value of 2.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items